Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Sleepio After Cancer Study (SACS). Digital CBT for Insomnia in Women Cancer Patients - A Randomised Controlled Trial

NCT05816460 is registered in ClinicalTrials.gov with University College Dublin as lead sponsor.

NCT NCT05816460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05816460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Sleepio After Cancer Study (SACS). Digital CBT for Insomnia in Women Cancer Patients - A Randomised Controlled Trial
Lead sponsor
University College Dublin
Phase
Not applicable
Overall status
Unknown status
Start date
May 22, 2023
Completion date
June 10, 2024
Enrollment
308 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, insomnia